BRAINSTORM CELL THERAPEUTICS INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $5.00K, a 82.76% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $20.00K, a 33.33% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $3.00K, a 40.00% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for fiscal 2021 was $5.00K, a 92.65% decline from fiscal 2020.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for fiscal 2020 was $68.00K, a 97.82% decline from fiscal 2019.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for fiscal 2019 was $3.13M, a 12404.00% increase from fiscal 2018.
- BRAINSTORM CELL THERAPEUTICS INC. stock issued during period, value, stock options exercised for fiscal 2018 was $25.00K, a 88.04% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $5.00K 10-K · filed 2023-03-30 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | |
| 2021-03-31 | $5.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $68.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $20.00K 10-Q · filed 2021-11-15 | $3.14M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $3.00K 10-Q · filed 2021-11-15 | $3.15M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | $29.00K 10-Q · filed 2021-11-15 | $3.15M derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $3.13M 10-K · filed 2021-02-04 |
| 2019-09-30 | $30.00K 10-Q · filed 2020-10-15 | |
| 2019-06-30 | $5.00K 10-Q · filed 2020-10-15 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $25.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $204.00K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | $204.00K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-03-31 | $25.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $209.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-17 | |
| 2015-12-31 | $109.00K 10-K · filed 2017-03-29 | |
| 2014-12-31 | $30.00K 10-K · filed 2016-03-09 | |
| 2013-12-31 | $1.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2015-08-13 | $8.00K 10-Q · filed 2015-08-13 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | |
| 2012-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | $137.00K 10-Q · filed 2014-05-13 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $152.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-06-30 | $117.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $300.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-03-31 | $20.00K 10-Q · filed 2012-05-11 | $208.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2011-12-31 | $15.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | $243.00K 10-Q · filed 2014-05-13 |
| 2011-09-30 | $148.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | |
| 2011-06-30 | $25.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-09-07 | |
| 2011-03-31 | $55.00K 10-Q · filed 2012-05-11 | |
| 2010-12-31 | $77.00K 10-Q · filed 2014-05-13 | |
| 2008-12-31 | $3.00K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |